Levothyroxine Overdosage Can Cause Tachycardia and Hypertension
Yes, increasing Synthroid by 20 mcg in a patient already experiencing elevated T4 with normal TSH can absolutely cause tachycardia and hypertension with diastolic blood pressure exceeding 100 mmHg—this represents iatrogenic hyperthyroidism from levothyroxine overdosage. 1
Mechanism of Cardiovascular Effects
The cardiovascular manifestations you're observing are classic adverse effects of levothyroxine overdosage:
- Tachycardia, arrhythmias, increased pulse and blood pressure are explicitly listed as cardiovascular adverse reactions to levothyroxine therapy due to therapeutic overdosage 1
- Palpitations, heart failure, angina, myocardial infarction, and cardiac arrest can also occur with excessive thyroid hormone 1
The hemodynamic effects of excess thyroid hormone (hyperthyroidism) include:
- Decreased systemic vascular resistance initially, but pulmonary artery hypertension is increasingly recognized 2
- Increased resting heart rate and left ventricular contractility 2
- Cardiac output can increase up to 300% from euthyroid state 2
- Persistent sinus tachycardia is a hallmark finding 2
Critical Clinical Context
The patient was already biochemically hyperthyroid before the dose increase (elevated T4 with normal TSH). Adding 20 mcg further exacerbated this state:
- When TSH is normal but T4 is elevated, the patient is already receiving excessive thyroid hormone replacement 2
- The dose should have been decreased by 12.5-25 mcg, not increased 2
- Even slight levothyroxine overdose carries risk of atrial fibrillation and osteoporotic fractures, especially in elderly patients 3
Immediate Management
Stop or reduce the levothyroxine dose immediately:
- If cardiac symptoms develop or worsen, reduce the dose or withhold for one week and restart at a lower dose 1
- Monitor blood pressure and heart rate closely 1
- Consider beta-blocker therapy to control heart rate and blood pressure symptoms 2
The goal is to lower heart rate to nearly normal, which will improve the tachycardia-mediated cardiovascular dysfunction 2
Monitoring and Dose Adjustment
- Repeat TSH and free T4 testing after 6-8 weeks following any dose change 2
- Given the long half-life of levothyroxine, dose adjustments should only be considered after 6-12 weeks 3
- The target is to achieve normal TSH and T4 levels, not just normal TSH alone 2
Common Pitfall to Avoid
Never increase levothyroxine when T4 is already elevated, even if TSH appears "normal"—this represents overtreatment and will precipitate or worsen cardiovascular complications 2, 1. The normal TSH in the setting of elevated T4 suggests the patient was already receiving excessive replacement, and the pituitary feedback mechanism was being overwhelmed.
Cardiovascular complications are the chief cause of death after treatment of hyperthyroidism, particularly in patients over 50 years of age 2. Prompt recognition and dose reduction are essential to prevent serious morbidity including myocardial infarction, heart failure, and arrhythmias 1.